JPRN-UMIN000028831已完成2 期
pfront autologous stem cell transplantation for primaly peripheral T cell lymphoma - Upfront ASCT for primary PTC
Tosei General Hospital Department of Hematology and Oncology0 个研究点目标入组 19 人开始时间: 2017年9月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 19
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with uncontroled DM even by the usage of insulin Patients with uncontroled HT Patients with past histories of myocardial infarction, congestive heart failure, and unstable angina Patients with the Ejection Frction less than 50 percent Patients with active double cacer Patients with active infection
研究者
相似试验
已完成
不适用
Autologous stem cell transplantation for patients with amyloid light chain (AL) amyloidosisAmyloidosisISRCTN01207094Dutch Haemato-Oncology Association (Stichting Hemato-Oncologie Volwassenen Nederland) (HOVON) (Netherlands)70
招募中
不适用
Autologous stem cell transplantation for the treatment of refractory Crohn*s disease: mechanisms of succesNL-OMON39547Sint Antonius Ziekenhuis15
进行中（未招募）
1 期
Controlled trial to assess low intensity autologous stem cell transplant in refractory Crohn's DiseaseEUCTR2017-002545-30-GBBarts Health NHS Trust99
进行中（未招募）
1 期
Stem cell transplantation in diffuse cutaneous systemic sclerosis: upfront therapy or rescue therapy after failure of immunosuppressantsDiffuse cutaneous systemic sclerosis according to the ACR/EULAR criteriaMedDRA version: 20.0Level: SOCClassification code: 10021428Term: Immune system disorders Class: 4CTIS2023-505877-34-00niversity Medical Center Utrecht88
尚未招募
不适用
pfront autologous hematopoietic stem cell transplantation versus immunosuppressive medication in early diffuse cutaneous systemic sclerosis: an international multicentre, open-label, randomized con-trolled trialSystemic SclerosisNL-OMON26075niversity Medical Centre Utrecht120